Cargando…
Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial
INTRODUCTION: Depression is the leading cause of life years lost due to disability. Appropriate prevention has the potential to reduce the incidence of new cases of depression, however, traditional prevention approaches face significant scalability issues. Prevention programmes delivered by via smar...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089262/ https://www.ncbi.nlm.nih.gov/pubmed/30007927 http://dx.doi.org/10.1136/bmjopen-2017-020510 |
_version_ | 1783346990524923904 |
---|---|
author | Deady, Mark Johnston, David A Glozier, Nick Milne, David Choi, Isabella Mackinnon, Andrew Mykletun, Arnstein Calvo, Rafael A Gayed, Aimee Bryant, Richard Christensen, Helen Harvey, Samuel B |
author_facet | Deady, Mark Johnston, David A Glozier, Nick Milne, David Choi, Isabella Mackinnon, Andrew Mykletun, Arnstein Calvo, Rafael A Gayed, Aimee Bryant, Richard Christensen, Helen Harvey, Samuel B |
author_sort | Deady, Mark |
collection | PubMed |
description | INTRODUCTION: Depression is the leading cause of life years lost due to disability. Appropriate prevention has the potential to reduce the incidence of new cases of depression, however, traditional prevention approaches face significant scalability issues. Prevention programmes delivered by via smartphone applications provide a potential solution. The workplace is an ideal setting to roll out this form of intervention, particularly among industries that are unlikely to access traditional health initiatives and whose workplace characteristics create accessibility and portability issues. The study aims to evaluate the effectiveness of a smartphone application designed to prevent depression and improve well-being. The effectiveness of the app as a universal, selective and indicated prevention tool will also be evaluated. METHODS AND ANALYSIS: A multicentre randomised controlled trial, to determine the effectiveness of the intervention compared with an active mood monitoring control in reducing depressive symptoms (primary outcome) and the prevalence of depression at 3 months, with secondary outcomes assessing well-being and work performance. Employees from a range of industries will be invited to participate. Participants with likely current depression at baseline will be excluded. Following baseline assessment, participants, blinded to their allocation, will be randomised to receive one of two versions of the application: headgear (a 30-day mental health intervention) or a control application (mood monitoring for 30 days). Both versions of the app contain a risk calculator to provide a measure of future risk. Analyses will be conducted within an intention-to-treat framework using mixed modelling, with additional analyses conducted to compare the moderating effect of baseline risk level and depression symptom severity on the intervention’s effectiveness. ETHICS AND DISSEMINATION: The current trial has received ethics approval from the University of New South Wales Human Research Ethics Committee (HC17021). Study results will be disseminated through peer-reviewed journals and conferences. TRIAL REGISTRATION NUMBER: ACTRN12617000548336; Results. |
format | Online Article Text |
id | pubmed-6089262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-60892622018-08-15 Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial Deady, Mark Johnston, David A Glozier, Nick Milne, David Choi, Isabella Mackinnon, Andrew Mykletun, Arnstein Calvo, Rafael A Gayed, Aimee Bryant, Richard Christensen, Helen Harvey, Samuel B BMJ Open Mental Health INTRODUCTION: Depression is the leading cause of life years lost due to disability. Appropriate prevention has the potential to reduce the incidence of new cases of depression, however, traditional prevention approaches face significant scalability issues. Prevention programmes delivered by via smartphone applications provide a potential solution. The workplace is an ideal setting to roll out this form of intervention, particularly among industries that are unlikely to access traditional health initiatives and whose workplace characteristics create accessibility and portability issues. The study aims to evaluate the effectiveness of a smartphone application designed to prevent depression and improve well-being. The effectiveness of the app as a universal, selective and indicated prevention tool will also be evaluated. METHODS AND ANALYSIS: A multicentre randomised controlled trial, to determine the effectiveness of the intervention compared with an active mood monitoring control in reducing depressive symptoms (primary outcome) and the prevalence of depression at 3 months, with secondary outcomes assessing well-being and work performance. Employees from a range of industries will be invited to participate. Participants with likely current depression at baseline will be excluded. Following baseline assessment, participants, blinded to their allocation, will be randomised to receive one of two versions of the application: headgear (a 30-day mental health intervention) or a control application (mood monitoring for 30 days). Both versions of the app contain a risk calculator to provide a measure of future risk. Analyses will be conducted within an intention-to-treat framework using mixed modelling, with additional analyses conducted to compare the moderating effect of baseline risk level and depression symptom severity on the intervention’s effectiveness. ETHICS AND DISSEMINATION: The current trial has received ethics approval from the University of New South Wales Human Research Ethics Committee (HC17021). Study results will be disseminated through peer-reviewed journals and conferences. TRIAL REGISTRATION NUMBER: ACTRN12617000548336; Results. BMJ Publishing Group 2018-07-13 /pmc/articles/PMC6089262/ /pubmed/30007927 http://dx.doi.org/10.1136/bmjopen-2017-020510 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Mental Health Deady, Mark Johnston, David A Glozier, Nick Milne, David Choi, Isabella Mackinnon, Andrew Mykletun, Arnstein Calvo, Rafael A Gayed, Aimee Bryant, Richard Christensen, Helen Harvey, Samuel B Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial |
title | Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial |
title_full | Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial |
title_fullStr | Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial |
title_full_unstemmed | Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial |
title_short | Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial |
title_sort | smartphone application for preventing depression: study protocol for a workplace randomised controlled trial |
topic | Mental Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089262/ https://www.ncbi.nlm.nih.gov/pubmed/30007927 http://dx.doi.org/10.1136/bmjopen-2017-020510 |
work_keys_str_mv | AT deadymark smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT johnstondavida smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT gloziernick smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT milnedavid smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT choiisabella smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT mackinnonandrew smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT mykletunarnstein smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT calvorafaela smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT gayedaimee smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT bryantrichard smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT christensenhelen smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial AT harveysamuelb smartphoneapplicationforpreventingdepressionstudyprotocolforaworkplacerandomisedcontrolledtrial |